Ric kayne and affiliates confirm nomination of two highly qualified candidates for election to athira pharma's board of directors

New york--(business wire)--richard a. (ric) kayne, who together with his affiliates beneficially owns approximately 4.8% of the outstanding shares of common stock of athira pharma, inc. (nasdaq: atha) (“athira” or the “company”), today confirmed that he has nominated himself and george w. bickerstaff, iii, the former chief financial officer of novartis pharma ag, for election to athira's board of directors (the “board”) at the upcoming 2022 annual meeting of shareholders. mr. kayne issued the f
ATHA Ratings Summary
ATHA Quant Ranking